Defibrillator Implantation in Patients with Nonischemic Systolic Heart FailureLars Køber, Steen Pehrson, Anna Margrethe Thøgersen et al.|New England Journal of Medicine|2016Cited by 1.7k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Blood-Pressure Targets in Comatose Survivors of Cardiac ArrestJesper Kjærgaard, Christian Hassager, Jacob Eifer Møller et al.|New England Journal of Medicine|2022Cited by 258
Oxygen Targets in Comatose Survivors of Cardiac ArrestHenrik Schmidt, Jacob Eifer Møller, Jesper Kjærgaard et al.|New England Journal of Medicine|2022Cited by 247
Duration of Device-Based Fever Prevention after Cardiac ArrestChristian Hassager, Jesper Kjærgaard, Henrik Schmidt et al.|New England Journal of Medicine|2022Cited by 93